| scholarly article | Q13442814 |
| P2093 | author name string | Howard N Hodis | |
| Thomas A Buchanan | |||
| Anny H Xiang | |||
| Miwa Kawakubo | |||
| Ruth K Peters | |||
| Chao-Ran Liu | |||
| Siri L Kjos | |||
| Cesar Ochoa | |||
| Aura Marroquin | |||
| Jose Goico | |||
| Ci-Hua Liu | |||
| P2860 | cites work | Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes | Q74555870 |
| Diagnosis and classification of diabetes mellitus | Q75205667 | ||
| Association between insulin resistance and endothelial dysfunction in type 2 diabetes and the effects of pioglitazone | Q79155712 | ||
| Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study | Q79615264 | ||
| Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes | Q22250883 | ||
| Evaluation of methods for the measurement of low-density lipoprotein cholesterol. | Q29547378 | ||
| Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial | Q29619886 | ||
| Suppression of nuclear factor-kappaB and stimulation of inhibitor kappaB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese | Q32132515 | ||
| Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus | Q34142970 | ||
| PPARgamma and atherosclerosis: effects on cell growth and movement | Q34462675 | ||
| Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial | Q34572519 | ||
| Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose | Q37006231 | ||
| The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia | Q41618288 | ||
| Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells | Q41734805 | ||
| Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects | Q41743849 | ||
| Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity | Q42832775 | ||
| Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes | Q43666606 | ||
| Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig | Q43719948 | ||
| Estrogen in the prevention of atherosclerosis. A randomized, double-blind, placebo-controlled trial | Q43813509 | ||
| Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women | Q44114894 | ||
| Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS). | Q44138520 | ||
| Effect of thiazolidinedione treatment on progression of subclinical atherosclerosis in premenopausal women at high risk for type 2 diabetes. | Q44329366 | ||
| Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect | Q44563941 | ||
| The effects of rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, on markers of endothelial cell activation, C-reactive protein, and fibrinogen levels in non-diabetic coronary artery disease patients | Q44671845 | ||
| Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus | Q44786820 | ||
| Effect of pioglitazone on carotid intima-media thickness and arterial stiffness in type 2 diabetic nephropathy patients | Q45064729 | ||
| TRIPOD (TRoglitazone In the Prevention Of Diabetes): a randomized, placebo-controlled trial of troglitazone in women with prior gestational diabetes mellitus. | Q45244072 | ||
| Improved common carotid elasticity and intima-media thickness measurements from computer analysis of sequential ultrasound frames. | Q46006629 | ||
| Effect of peroxisome proliferator-activated receptor gamma agonist treatment on subclinical atherosclerosis in patients with insulin-requiring type 2 diabetes | Q46083123 | ||
| The prevalence of the metabolic syndrome in a danish population of women with previous gestational diabetes mellitus is three-fold higher than in the general population | Q46446011 | ||
| Pioglitazone decreases carotid intima-media thickness independently of glycemic control in patients with type 2 diabetes mellitus: results from a controlled randomized study | Q46481435 | ||
| Evaluation of computerized edge tracking for quantifying intima-media thickness of the common carotid artery from B-mode ultrasound images | Q46735534 | ||
| Comparative study on the efficacy of pioglitazone in Caucasian and Maori-Polynesian patients with poorly controlled type 2 diabetes | Q51468986 | ||
| Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. | Q51598262 | ||
| Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. | Q51679983 | ||
| MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. | Q54421540 | ||
| Effect of Rosiglitazone on Endothelial Function and Inflammatory Markers in Patients With the Metabolic Syndrome | Q58829130 | ||
| Carotid artery intimal-medial thickness distribution in general populations as evaluated by B-mode ultrasound. ARIC Investigators | Q60692542 | ||
| P433 | issue | 1 | |
| P921 | main subject | gestational diabetes | Q126691 |
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 207-214 | |
| P577 | publication date | 2007-12-04 | |
| P1433 | published in | Atherosclerosis | Q4813570 |
| P1476 | title | Effect of pioglitazone on progression of subclinical atherosclerosis in non-diabetic premenopausal Hispanic women with prior gestational diabetes | |
| P478 | volume | 199 |
| Q38205374 | Cardiovascular risk stratification and management in pre-diabetes |
| Q34721194 | Carotid intima-media thickness as a surrogate marker of cardiovascular disease in diabetes |
| Q46075634 | Differences in cardiovascular risk profile based on relationship between post-load plasma glucose and fasting plasma levels. |
| Q33727430 | Early exposure of the pregestational intrauterine and postnatal growth-restricted female offspring to a peroxisome proliferator-activated receptor-{gamma} agonist |
| Q45340364 | Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trial |
| Q44854158 | Evaluation of postpartum carbohydrate intolerance and cardiovascular risk factors in women with gestational diabetes |
| Q38170410 | Gestational diabetes mellitus and cardiovascular risk after pregnancy. |
| Q37812190 | Gestational diabetes mellitus: Taking it to heart |
| Q37950851 | Gestational diabetes: implications for cardiovascular health |
| Q33687575 | Late cardiovascular consequences of gestational diabetes mellitus |
| Q92434438 | Low dose chloroquine decreases insulin resistance in human metabolic syndrome but does not reduce carotid intima-media thickness |
| Q34405375 | One-hour postload plasma glucose levels are associated with kidney dysfunction |
| Q36582644 | Osteoprotegerin as a marker of atherosclerosis in diabetic patients. |
| Q42772072 | Outcomes in women with history of gestational diabetes mellitus. Screening and prevention of type 2 diabetes mellitus. Literature review |
| Q24186319 | Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack |
| Q24201174 | Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attack |
| Q90611354 | Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack |
| Q47380989 | Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack. |
| Q37537808 | Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors |
| Q50179665 | Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction |
| Q34073458 | Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study |
| Q36736281 | Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS) |
| Q37394037 | Thiazolidinediones: effects on the development and progression of type 2 diabetes and associated vascular complications |
Search more.